The research world and pharmaceutical companies are joining forces.
Last month there was talk of a 20 percent cut in funding for the National Institutes of Health, which is the primary source of academic life sciences grants. Prompted by science media concern, much of the public wondered about the potential impact on biomedical research. Pharmacologist David Kroll of Chemical & Engineering News expressed it well on Twitter:
“Combine the administration’s harsh climate toward pharma profits with a proposed 20% NIH budget cut…where will new drugs come from?”
It’s a very common question. People who are not familiar with the drug discovery process often believe that government-funded research is the main driver of innovation. But this is false. Industry invents almost all drugs. When asked about what drugs are discovered in academia, Kroll noted that they don’t do much but also expressed where academia does have importance (1).
|Read Full Article: Hepatitis C: Academia And Industry Work Together To Find A Cure | American Council on Science and Health|